Form EFFECT CTI BIOPHARMA CORP

February 1, 2018 6:02 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 31, 2018
Accession Number: 0000891293-18-000034
Submission Type: POS AM
CIK: 0000891293
Company Name: CTI BIOPHARMA CORP
File Number: 333-221382

Categories

SEC Filings